Related references
Note: Only part of the references are listed.The E3 ubiquitin ligase EDD regulates S-phase and G2/M DNA damage checkpoints
Marcia A. Munoz et al.
CELL CYCLE (2007)
Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor I as a prognostic marker for advanced-stage serous ovarian adenocarcinomas
Michael J. Birrer et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
EDD mediates DNA damage-induced activation of CHK2
Michelle J. Henderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Identification of a common polymorphism in the TopBP1 gene associated with hereditary susceptibility to breast and ovarian cancer
Sanna-Maria Karppinen et al.
EUROPEAN JOURNAL OF CANCER (2006)
Drug resistance in ovarian cancer: The emerging importance of gene transcription and spatio-temporal regulation of resistance
A Richardson et al.
DRUG RESISTANCE UPDATES (2005)
Genorne-wide transcriptional analysis of carboplatin response in chemosensitive and chemoresistant ovarian cancer cells
D Peters et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Inducible degradation of checkpoint kinase 2 links to cisplatin-induced resistance in ovarian cancer cells
PL Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Lymphoid gene expression as a predictor of risk of secondary brain tumors
MJ Edick et al.
GENES CHROMOSOMES & CANCER (2005)
DNA damage tumor suppressor genes and genomic instability
N Motoyama et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2004)
Alteration of cell cycle regulators correlates with survival in epithelial ovarian cancer patients
Y Hashiguchi et al.
HUMAN PATHOLOGY (2004)
Somatic mutations and altered expression of the candidate tumor suppressors CSNK1ε, DLG1, and EDD/hHYD in mammary ductal carcinoma
TJ Fuja et al.
CANCER RESEARCH (2004)
The ubiquitin-mediated protein degradation pathway in cancer: therapeutic implications
AM Burger et al.
EUROPEAN JOURNAL OF CANCER (2004)
Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer
YP Zeng et al.
CLINICAL CANCER RESEARCH (2004)
Edd, the murine hyperplastic disc gene, is essential for yolk sac vascularization and chorioallantoic fusion
DN Saunders et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer
A Bali et al.
CLINICAL CANCER RESEARCH (2004)
Overexpression of the cell adhesion molecules DDR1, claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer
VA Heinzelmann-Schwarz et al.
CLINICAL CANCER RESEARCH (2004)
Suppression of the transformed phenotype and induction of differentiation-like characteristics in cultured ovarian tumor cells by chronic treatment with progesterone
M Blumenthal et al.
MOLECULAR CARCINOGENESIS (2003)
Progesterone-induced apoptosis in immortalized normal and malignant human ovarian surface epithelial cells involves enhanced expression of FasL
V Syed et al.
ONCOGENE (2003)
EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer
JL Clancy et al.
ONCOGENE (2003)
Ovarian cancer: Strategies for overcoming resistance to chemotherapy
R Agarwal et al.
NATURE REVIEWS CANCER (2003)
Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors
T Taniguchi et al.
NATURE MEDICINE (2003)
Improved survival in women with BRCA-associated ovarian carcinoma
I Cass et al.
CANCER (2003)
Identification of novel ERK2 substrates through use of an engineered kinase and ATP analogs
ST Eblen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Role of BRCA1 in cellular resistance to paclitaxel and ionizing radiation in an ovarian cancer cell line carrying a defective BRCA1
CY Zhou et al.
ONCOGENE (2003)
Resistance to chemotherapy in advanced ovarian cancer: mechanisms and current strategies
PA Vasey
BRITISH JOURNAL OF CANCER (2003)
EDD, the human hyperplastic discs protein, has a role in progesterone receptor coactivation and potential involvement in DNA damage response
MJ Henderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cooperation of HECT-domain ubiquitin ligase hHYD and DNA topoisomerase II-binding protein for DNA damage response
Y Honda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A DNA damage-regulated BRCT-containing protein, TopBP1, is required for cell survival
K Yamane et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation
R Hashizume et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Ovarian surface epithelium: Biology, endocrinology, and pathology
N Auersperg et al.
ENDOCRINE REVIEWS (2001)
Share Paper
